These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34804741)

  • 1. Reversal of Opioid Intoxication in an Infant With Intrauterine Growth Restriction With a Single Dose of Naloxone.
    Timalsina U; Andrasovich A; Kupferman FE; Viswanathan K; Ericksen K
    Cureus; 2021 Oct; 13(10):e18908. PubMed ID: 34804741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone for opiate-exposed newborn infants.
    Moe-Byrne T; Brown JV; McGuire W
    Cochrane Database Syst Rev; 2013 Feb; (2):CD003483. PubMed ID: 23450541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Fatal Case of Opioid Intoxication After Raw Poppy Plant Ingestion.
    Bozan G; Ulukapi HB; Oncul U; Levent S; Dinleyici EC
    Cureus; 2021 Feb; 13(2):e13176. PubMed ID: 33717721
    [No Abstract]   [Full Text] [Related]  

  • 4. Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users.
    Levy-Cooperman N; Schoedel KA; Reiz JL; Thompson D; Chakaraborty B; Geoffroy P; Michalko KJ
    J Opioid Manag; 2016; 12(3):165-80. PubMed ID: 27435437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial.
    Zamani N; Buckley NA; Hassanian-Moghaddam H
    Crit Care; 2020 Feb; 24(1):44. PubMed ID: 32033582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxycodone/naloxone preparation can cause acute withdrawal symptoms when misused parenterally or taken orally.
    Wong A; Macleod D; Robinson J; Koutsogiannis Z; Graudins A; Greene SL
    Clin Toxicol (Phila); 2015; 53(8):815-8. PubMed ID: 26109423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of Opioid-Induced Ventilatory Depression Using Low-Dose Naloxone (0.04 mg): a Case Series.
    Kim HK; Nelson LS
    J Med Toxicol; 2016 Mar; 12(1):107-10. PubMed ID: 26289651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis.
    Link HM; Jones H; Miller L; Kaltenbach K; Seligman N
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100179. PubMed ID: 33345863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative analgesia after radical prostatectomy with high-dose intrathecal morphine and intravenous naloxone: a retrospective review.
    Rebel A; Sloan P; Andrykowski M
    J Opioid Manag; 2009; 5(6):331-9. PubMed ID: 20073407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the appropriateness of naloxone administration to patients receiving long-term opioid therapy.
    Facey C; Brooks D; Boland JW
    Hosp Pract (1995); 2016; 44(2):86-91. PubMed ID: 26837434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimens: a retrospective cohort study.
    Purssell R; Godwin J; Moe J; Buxton J; Crabtree A; Kestler A; DeWitt C; Scheuermeyer F; Erdelyi S; Balshaw R; Rowe A; Cochrane CK; Ng B; Jiang A; Risi A; Ho V; Brubacher JR
    Clin Toxicol (Phila); 2021 Jan; 59(1):38-46. PubMed ID: 32401548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of naloxone on the breathing pattern of a newborn exposed to maternal opiates.
    van Vonderen JJ; Siew ML; Hooper SB; de Boer MA; Walther FJ; te Pas AB
    Acta Paediatr; 2012 Jul; 101(7):e309-12. PubMed ID: 22372574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of Pediatric Opioid Toxicity with Take-Home Naloxone: a Case Report.
    Lebin JA; Chen BC; Valento MJ
    J Med Toxicol; 2019 Apr; 15(2):134-135. PubMed ID: 30632074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-analgesic effects of opioids: opioid-induced respiratory depression.
    Boom M; Niesters M; Sarton E; Aarts L; Smith TW; Dahan A
    Curr Pharm Des; 2012; 18(37):5994-6004. PubMed ID: 22747535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Oral Nanoparticle Formulation of Sustained Release Naloxone with Mild Withdrawal Symptoms in Mice.
    Madison CA; Arora M; Kumar MNVR; Eitan S
    ACS Chem Neurosci; 2020 Jul; 11(13):1955-1964. PubMed ID: 32491828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone treatment in opioid addiction: the risks and benefits.
    van Dorp E; Yassen A; Dahan A
    Expert Opin Drug Saf; 2007 Mar; 6(2):125-32. PubMed ID: 17367258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population.
    Jumah NA; Edwards C; Balfour-Boehm J; Loewen K; Dooley J; Gerber Finn L; Kelly L
    BMJ Open; 2016 Oct; 6(10):e011774. PubMed ID: 27799240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter prospective study of neonatal outcomes at less than 32 weeks associated with indications for maternal admission and delivery.
    Garite TJ; Combs CA; Maurel K; Das A; Huls K; Porreco R; Reisner D; Lu G; Bush M; Morris B; Bleich A;
    Am J Obstet Gynecol; 2017 Jul; 217(1):72.e1-72.e9. PubMed ID: 28267444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid-induced respiratory effects: new data on buprenorphine.
    Dahan A
    Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of methylergonovine induced respiratory depression in a newborn with naloxone.
    Sullivan R; Nelsen J; Duggineni S; Holland M
    Clin Toxicol (Phila); 2013 Jan; 51(1):47-9. PubMed ID: 23206235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.